PSNL PERSONALIS
Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about PERSONALIS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 11 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Average target is not above the current price
- Russell 2000 · Safest consensus · 6MNot scored · Average target is not above the current price
Recent analyst activity · last 90 days
Our tracked history has 6 reports on PSNL from 6 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Mark Massaro | Hold | 6 Oct 2026 | — |
| Craig-Hallum | William B Bonello | Hold | 24 Aug 2026 | 16.25 USD |
| Guggenheim | Subbu Nambi | Buy | 18 Sep 2026 | 13.00 USD |
| H.C. Wainwright | Unnamed analyst | Buy | 11 Nov 2025 | 13.00 USD |
| Lake Street Capital Markets | Thomas Flaten | Hold | 20 Jul 2026 | 16.25 USD |
| Morgan Stanley | Tejas Savant | Hold | 9 Jul 2026 | 13.00 USD |
| Needham | Mike Matson | Hold | 20 Jul 2026 | — |
| TD Cowen | Unnamed analyst | Buy | 15 Jul 2026 | — |
| UBS | Unnamed analyst | Hold | 6 Oct 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 7 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.